PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.
An Act To Inform Patients of the Dangers of Addicting Opioids
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  32 MRSA §2210, sub-§6  is enacted to read:
 
6.  Opioid medication information disclosure.     Prior to prescribing an opioid medication to a patient, an individual licensed under this chapter whose scope of practice includes prescribing opioid medication shall inform the patient of the risks of using the opioid medication, including but not limited to the risk of forming an addiction to the opioid medication, and receive from the patient a written certification that the patient has been provided that information.
Sec. 2.  32 MRSA §2600-C, sub-§6  is enacted to read:
 
6.  Opioid medication information disclosure.     Prior to prescribing an opioid medication to a patient, an individual licensed under this chapter whose scope of practice includes prescribing opioid medication shall inform the patient of the risks of using the opioid medication, including but not limited to the risk of forming an addiction to the opioid medication, and receive from the patient a written certification that the patient has been provided that information.
Sec. 3.  32 MRSA §3300-F, sub-§6  is enacted to read:
 
6.  Opioid medication information disclosure.     Prior to prescribing an opioid medication to a patient, an individual licensed under this chapter whose scope of practice includes prescribing opioid medication shall inform the patient of the risks of using the opioid medication, including but not limited to the risk of forming an addiction to the opioid medication, and receive from the patient a written certification that the patient has been provided that information.
Sec. 4.  32 MRSA §3657, sub-§6  is enacted to read:
 
6.  Opioid medication information disclosure.     Prior to prescribing an opioid medication to a patient, an individual licensed under this chapter whose scope of practice includes prescribing opioid medication shall inform the patient of the risks of using the opioid medication, including but not limited to the risk of forming an addiction to the opioid medication, and receive from the patient a written certification that the patient has been provided that information.
Sec. 5.  32 MRSA §18308, sub-§6  is enacted to read:
 
6.  Opioid medication information disclosure.     Prior to prescribing an opioid medication to a patient, an individual licensed under this chapter whose scope of practice includes prescribing opioid medication shall inform the patient of the risks of using the opioid medication, including but not limited to the risk of forming an addiction to the opioid medication, and receive from the patient a written certification that the patient has been provided that information.
 
SUMMARY
This bill requires that a health care provider who is a prescriber of opioid medication must, before prescribing an opioid medication, inform the patient of the risks of using the opioid medication, including but not limited to the risk of forming an addiction to the opioid medication, and receive from the patient a written certification that the patient has been provided that information.